Annual D&A
$1.87 M
-$379.00 K-16.87%
30 April 2024
Summary:
Champions Oncology annual depreciation & amortization is currently $1.87 million, with the most recent change of -$379.00 thousand (-16.87%) on 30 April 2024. During the last 3 years, it has risen by +$683.00 thousand (+57.69%). CSBR annual D&A is now -16.87% below its all-time high of $2.25 million, reached on 30 April 2023.CSBR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$449.00 K
-$8000.00-1.75%
31 July 2024
Summary:
Champions Oncology quarterly depreciation & amortization is currently $449.00 thousand, with the most recent change of -$8000.00 (-1.75%) on 31 July 2024. Over the past year, it has dropped by -$35.00 thousand (-7.23%). CSBR quarterly D&A is now -22.98% below its all-time high of $583.00 thousand, reached on 30 April 2023.CSBR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.87 M
+$4000.00+0.21%
31 July 2024
Summary:
Champions Oncology TTM depreciation & amortization is currently $1.87 million, with the most recent change of +$4000.00 (+0.21%) on 31 July 2024. Over the past year, it has dropped by -$216.00 thousand (-10.35%). CSBR TTM D&A is now -16.70% below its all-time high of $2.25 million, reached on 30 April 2023.CSBR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.9% | -7.2% | -10.3% |
| 3 y3 years | +57.7% | +29.8% | +48.1% |
| 5 y5 years | +208.1% | +152.3% | +168.4% |
CSBR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -16.9% | +57.7% | -23.0% | +29.8% | -16.7% | +48.1% |
| 5 y | 5 years | -16.9% | +208.1% | -23.0% | +152.3% | -16.7% | +168.4% |
| alltime | all time | -16.9% | >+9999.0% | -23.0% | +346.2% | -16.7% | +1252.1% |
Champions Oncology Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $449.00 K(-1.8%) | $1.87 M(+0.2%) |
| Apr 2024 | $1.87 M(-16.9%) | $457.00 K(-5.0%) | $1.87 M(-6.3%) |
| Jan 2024 | - | $481.00 K(-0.6%) | $1.99 M(-4.5%) |
| Oct 2023 | - | $484.00 K(+8.8%) | $2.09 M(-3.5%) |
| July 2023 | - | $445.00 K(-23.7%) | $2.16 M(-3.7%) |
| Apr 2023 | $2.25 M(+38.0%) | $583.00 K(+1.4%) | $2.25 M(+0.7%) |
| Jan 2023 | - | $575.00 K(+2.7%) | $2.23 M(+8.7%) |
| Oct 2022 | - | $560.00 K(+6.1%) | $2.05 M(+11.6%) |
| July 2022 | - | $528.00 K(-7.0%) | $1.84 M(+13.0%) |
| Apr 2022 | $1.63 M(+37.4%) | $568.00 K(+43.4%) | $1.63 M(+19.5%) |
| Jan 2022 | - | $396.00 K(+14.5%) | $1.36 M(+7.8%) |
| Oct 2021 | - | $346.00 K(+9.1%) | $1.26 M(+3.2%) |
| July 2021 | - | $317.00 K(+4.6%) | $1.22 M(+3.4%) |
| Apr 2021 | $1.18 M(+43.5%) | $303.00 K(+2.0%) | $1.18 M(+5.1%) |
| Jan 2021 | - | $297.00 K(-3.3%) | $1.13 M(+7.4%) |
| Oct 2020 | - | $307.00 K(+10.8%) | $1.05 M(+14.0%) |
| July 2020 | - | $277.00 K(+12.6%) | $920.00 K(+11.5%) |
| Apr 2020 | $825.00 K(+36.1%) | $246.00 K(+12.3%) | $825.00 K(+9.7%) |
| Jan 2020 | - | $219.00 K(+23.0%) | $752.00 K(+7.9%) |
| Oct 2019 | - | $178.00 K(-2.2%) | $697.00 K(+4.0%) |
| July 2019 | - | $182.00 K(+5.2%) | $670.00 K(+10.6%) |
| Apr 2019 | $606.00 K(+68.3%) | $173.00 K(+5.5%) | $606.00 K(+12.2%) |
| Jan 2019 | - | $164.00 K(+8.6%) | $540.00 K(+8.7%) |
| Oct 2018 | - | $151.00 K(+28.0%) | $497.00 K(+14.0%) |
| July 2018 | - | $118.00 K(+10.3%) | $436.00 K(+21.1%) |
| Apr 2018 | $360.00 K(+114.3%) | $107.00 K(-11.6%) | $360.00 K(+22.4%) |
| Jan 2018 | - | $121.00 K(+34.4%) | $294.00 K(+38.0%) |
| Oct 2017 | - | $90.00 K(+114.3%) | $213.00 K(+29.1%) |
| July 2017 | - | $42.00 K(+2.4%) | $165.00 K(-1.8%) |
| Apr 2017 | $168.00 K(+7.7%) | $41.00 K(+2.5%) | $168.00 K(-0.6%) |
| Jan 2017 | - | $40.00 K(-4.8%) | $169.00 K(+1.2%) |
| Oct 2016 | - | $42.00 K(-6.7%) | $167.00 K(+1.8%) |
| July 2016 | - | $45.00 K(+7.1%) | $164.00 K(+5.1%) |
| Apr 2016 | $156.00 K(-27.1%) | $42.00 K(+10.5%) | $156.00 K(-3.7%) |
| Jan 2016 | - | $38.00 K(-2.6%) | $162.00 K(-10.0%) |
| Oct 2015 | - | $39.00 K(+5.4%) | $180.00 K(-7.7%) |
| July 2015 | - | $37.00 K(-22.9%) | $195.00 K(-8.9%) |
| Apr 2015 | $214.00 K(+0.5%) | $48.00 K(-14.3%) | $214.00 K(-3.2%) |
| Jan 2015 | - | $56.00 K(+3.7%) | $221.00 K(0.0%) |
| Oct 2014 | - | $54.00 K(-3.6%) | $221.00 K(+0.9%) |
| July 2014 | - | $56.00 K(+1.8%) | $219.00 K(+2.8%) |
| Apr 2014 | $213.00 K | $55.00 K(-1.8%) | $213.00 K(+2.4%) |
| Jan 2014 | - | $56.00 K(+7.7%) | $208.00 K(+3.0%) |
| Oct 2013 | - | $52.00 K(+4.0%) | $202.00 K(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2013 | - | $50.00 K(0.0%) | $199.00 K(-2.0%) |
| Apr 2013 | $203.00 K(+93.3%) | $50.00 K(0.0%) | $203.00 K(+5.2%) |
| Jan 2013 | - | $50.00 K(+2.0%) | $193.00 K(+21.4%) |
| Oct 2012 | - | $49.00 K(-9.3%) | $159.00 K(+22.3%) |
| July 2012 | - | $54.00 K(+35.0%) | $130.00 K(+23.8%) |
| Apr 2012 | $105.00 K(+150.0%) | $40.00 K(+150.0%) | $105.00 K(+36.4%) |
| Jan 2012 | - | $16.00 K(-20.0%) | $77.00 K(+8.5%) |
| Oct 2011 | - | $20.00 K(-31.0%) | $71.00 K(+16.4%) |
| July 2011 | - | $29.00 K(+141.7%) | $61.00 K(+45.2%) |
| Apr 2011 | $42.00 K(+31.3%) | $12.00 K(+20.0%) | $42.00 K(+10.5%) |
| Jan 2011 | - | $10.00 K(0.0%) | $38.00 K(+5.6%) |
| Oct 2010 | - | $10.00 K(0.0%) | $36.00 K(+5.9%) |
| July 2010 | - | $10.00 K(+25.0%) | $34.00 K(+6.3%) |
| Apr 2010 | $32.00 K(+700.0%) | $8000.00(0.0%) | $32.00 K(+14.3%) |
| Jan 2010 | - | $8000.00(0.0%) | $28.00 K(-117.2%) |
| Oct 2009 | - | $8000.00(0.0%) | -$162.40 K(-1453.3%) |
| July 2009 | - | $8000.00(+100.0%) | $12.00 K(+200.0%) |
| Apr 2009 | $4000.00(-63.6%) | $4000.00(-102.2%) | $4000.00(-103.7%) |
| Jan 2009 | - | -$182.40 K(-200.0%) | -$109.00 K(-191.5%) |
| Oct 2008 | - | $182.40 K(-267.3%) | $119.10 K(<-9900.0%) |
| Apr 2008 | - | -$109.00 K(-338.5%) | -$100.00(-100.1%) |
| Jan 2008 | - | $45.70 K(+25.5%) | $108.90 K(+72.3%) |
| Oct 2007 | - | $36.40 K(+35.8%) | $63.20 K(+135.8%) |
| July 2007 | - | $26.80 K(-210.7%) | $26.80 K(+121.5%) |
| Apr 2007 | $11.00 K(-77.3%) | - | - |
| Jan 2005 | - | -$24.20 K(-200.0%) | $12.10 K(-75.0%) |
| Oct 2004 | - | $24.20 K(+100.0%) | $48.40 K(0.0%) |
| Apr 2004 | $48.40 K(0.0%) | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Jan 2004 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Oct 2003 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| July 2003 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Apr 2003 | $48.40 K(0.0%) | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Jan 2003 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Oct 2002 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| July 2002 | - | $12.10 K(0.0%) | $48.40 K(0.0%) |
| Apr 2002 | $48.40 K(-14.2%) | $12.10 K(0.0%) | $48.40 K(-14.2%) |
| Jan 2002 | - | $12.10 K(0.0%) | $56.40 K(0.0%) |
| Oct 2001 | - | $12.10 K(0.0%) | $56.40 K(0.0%) |
| July 2001 | - | $12.10 K(-39.8%) | $56.40 K(0.0%) |
| Apr 2001 | $56.40 K(+8.9%) | $20.10 K(+66.1%) | $56.40 K(+55.4%) |
| Jan 2001 | - | $12.10 K(0.0%) | $36.30 K(+50.0%) |
| Oct 2000 | - | $12.10 K(0.0%) | $24.20 K(+100.0%) |
| July 2000 | - | $12.10 K | $12.10 K |
| Apr 2000 | $51.80 K | - | - |
FAQ
- What is Champions Oncology annual depreciation & amortization?
- What is the all time high annual D&A for Champions Oncology?
- What is Champions Oncology annual D&A year-on-year change?
- What is Champions Oncology quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Champions Oncology?
- What is Champions Oncology quarterly D&A year-on-year change?
- What is Champions Oncology TTM depreciation & amortization?
- What is the all time high TTM D&A for Champions Oncology?
- What is Champions Oncology TTM D&A year-on-year change?
What is Champions Oncology annual depreciation & amortization?
The current annual D&A of CSBR is $1.87 M
What is the all time high annual D&A for Champions Oncology?
Champions Oncology all-time high annual depreciation & amortization is $2.25 M
What is Champions Oncology annual D&A year-on-year change?
Over the past year, CSBR annual depreciation & amortization has changed by -$379.00 K (-16.87%)
What is Champions Oncology quarterly depreciation & amortization?
The current quarterly D&A of CSBR is $449.00 K
What is the all time high quarterly D&A for Champions Oncology?
Champions Oncology all-time high quarterly depreciation & amortization is $583.00 K
What is Champions Oncology quarterly D&A year-on-year change?
Over the past year, CSBR quarterly depreciation & amortization has changed by -$35.00 K (-7.23%)
What is Champions Oncology TTM depreciation & amortization?
The current TTM D&A of CSBR is $1.87 M
What is the all time high TTM D&A for Champions Oncology?
Champions Oncology all-time high TTM depreciation & amortization is $2.25 M
What is Champions Oncology TTM D&A year-on-year change?
Over the past year, CSBR TTM depreciation & amortization has changed by -$216.00 K (-10.35%)